biote Corp.
BTMD Healthcare Medical Care Facilities
biote Corp.’s revenue for fiscal 2025 (year ended December 2025) was $192.2 million, down 2.52% from fiscal 2024. In the quarter to June 2026, revenue fell 9.48%, EPS fell 330.0%, free cash flow fell 174.2% and total debt rose 16.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow BTMD
biote Corp. (BTMD) P/E ratio
As of 16 October 2026, biote Corp. (BTMD) trades at a P/E ratio of 6.8×. Over the past ten years it has ranged from 0.0× (March 2024) to 43.9× (June 2024); the current reading is higher than 73% of that period. That is below the Medical Care Facilities industry median of 20.6× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 3.0× | (89.73%) |
| FY2024 | 29.4× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.3× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 11.8× | 328.75% |
| Mar 2026 | 2.8× | (8.87%) |
| Dec 2025 | 3.0× | (7.29%) |
| Sep 2025 | 3.3× | (18.88%) |
| 17 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| DCGO DocGo Inc. compare | n/m |
| PARK Park Dental Partners, Inc. compare | n/m |
| CCM Concord Medical Services Holdings Limited compare | n/m |
| AIRS AirSculpt Technologies, Inc. compare | n/m |
| PIII P3 Health Partners Inc. compare | n/m |
| PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR compare | n/m |
| CCEL Cryo-Cell International Inc. compare | n/m |
| BTMD biote Corp. | 6.8× |
| JYNT The Joint Corp. compare | 26.0× |
| Medical Care Facilities industry median | 20.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)